10.6084/m9.figshare.12602219.v1
Mourad F. Rezk
Mourad F.
Rezk
Burkhard Pieper
Burkhard
Pieper
Unlocking the Value of Anti-TNF Biosimilars: Reducing Disease Burden and Improving Outcomes in Chronic Immune-Mediated Inflammatory Disease: A Narrative Review
Adis Journals
2020
Access to treatment
Anti-TNF
Biosimilars
Disease burden
Early treatment
IMIDs
Maintenance of remission
Patient outcomes
Rheumatology
2020-07-14 14:53:56
Media
https://adisjournals.figshare.com/articles/media/Unlocking_the_Value_of_Anti-TNF_Biosimilars_Reducing_Disease_Burden_and_Improving_Outcomes_in_Chronic_Immune-Mediated_Inflammatory_Disease_A_Narrative_Review/12602219
<p><strong>Article full
text</strong></p>
<p><br></p>
<p><br>
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author
disclosure statements, please see the full text online (see “read the
peer-reviewed publication” opposite). </p>
<p>© The authors, CC-BY-NC 2020.<b> </b></p>